Baillie Gifford & Co’s Sage Therapeutics SAGE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-63,333	Closed	-$688K	–	293
2024 Q2	$688K	Sell	63,333 -17,483	-22%	-$224K	﹤0.01%	261
2024 Q1	$1.51M	Sell	80,816 -3,949	-5%	-$91.1K	﹤0.01%	251
2023 Q4	$1.84M	Sell	84,765 -3,742	-4%	-$74.2K	﹤0.01%	254
2023 Q3	$1.82M	Sell	88,507 -5,212	-6%	-$151K	﹤0.01%	255
2023 Q2	$4.41M	Sell	93,719 -1,326	-1%	-$66K	﹤0.01%	244
2023 Q1	$3.99M	Buy	95,045 +160	+0.2%	+$6.88K	﹤0.01%	245
2022 Q4	$3.62M	Buy	94,885 +3,490	+4%	+$133K	﹤0.01%	250
2022 Q3	$3.58M	Buy	91,395 +2,949	+3%	+$114K	﹤0.01%	253
2022 Q2	$2.86M	Sell	88,446 -10,320	-10%	-$346K	﹤0.01%	257
2022 Q1	$3.27M	Buy	98,766 +8,394	+9%	+$316K	﹤0.01%	261
2021 Q4	$3.85M	Buy	90,372 +4,074	+5%	+$171K	﹤0.01%	261
2021 Q3	$3.82M	Buy	86,298 +6,033	+8%	+$277K	﹤0.01%	262
2021 Q2	$4.56M	Buy	80,265 +10,516	+15%	+$743K	﹤0.01%	259
2021 Q1	$5.22M	Buy	69,749 +36,833	+112%	+$3.02M	﹤0.01%	252
2020 Q4	$2.85M	Buy	32,916 +15,886	+93%	+$1.17M	﹤0.01%	240
2020 Q3	$1.04M	Buy	17,030 +15,440	+971%	+$783K	﹤0.01%	239
2020 Q2	$66K	Buy	1,590 +711	+81%	+$25.8K	﹤0.01%	241
2020 Q1	$25K	Buy	879 +389	+79%	+$22.5K	﹤0.01%	224
2019 Q4	$35K	Hold	490	–	–	﹤0.01%	225
2019 Q3	$69K	Buy	+490	New	+$82K	﹤0.01%	221